Newsletter Sign UpStay updated on news regarding the Kanzius Foundation and the Kanzius Noninvasive Radiowave Cancer Treatment by receiving our quarterly newsletter, the wave!
Like This PageThe Kanzius research team makes strides each and everyday towards a better way to treat cancer. We encourage you to review the research updates, as well as the most recent cancer research of the Noninvasive Radiowave Cancer Treatment. For a more in-depth description of the research taking place, retrieve published research journals of the Kanzius research team.
| Displaying 1 - 10 (of 22) · View All | < Prev of 3 Next > |
| Curley Gives Spring 2013 Research Update: FDA the Number One Priority |
| Posted on Thursday, March 28, 2013 at 12:00 PM |
 The entire laboratory team is deeply grateful to the Kanzius Cancer Research Foundation, its generous donors and committed Board of Directors for their continued and unflagging support. Our mission and goals are as focused as ever and we will get the Kanzius Noninvasive Radiowave Cancer Treatment to human clinical trials as soon as possible! Read More » |
|
|
| Kanzius Researchers Go a New Direction to Get to Human Trials Sooner |
| Posted on Monday, November 12, 2012 at 4:45 PM |
|
Each new year brings a wave of promises and goals that we make to better our lives. The path to reaching these goals always begins with the best intentions, but more often than not, a new route is discovered along the way. Kanzius Cancer Research Foundation doesn’t make New Year’s Resolutions, it sets goals. Our ultimate goal is to get FDA approval for the Kanzius Noninvasive Radiowave Cancer Treatment. While it has taken a lot of hard work over the years to get to this point in research, knowledge, and awareness, our lead researchers have learned that they need to alter the path to the FDA as new discoveries are made. Read More » |
|
|
| Breaking News from Houston |
| Posted on Saturday, July 14, 2012 at 10:31 AM |
|
BREAKING NEWS FROM HOUSTON! Dr. StevenCurley, the lead investigator of the Kanzius Noninvasive Radiowave Cancer Treatment project at MD Anderson Cancer Center just informed us that large, non-human laboratory subjects are on the GenV Kanzius RF table, have been undergoing extensive testing and that the initial results are extremely exciting! |
|
|
| Cancer Researchers Continue Work On John Kanzius' Machine |
| Posted on Saturday, May 5, 2012 at 11:57 AM |
|
HOUSTON, Texas (KDKA) — One of the nation’s top cancer doctors is working with a machine that could end up being a major breakthrough in treating the killer disease. Read More » |
|
|
| New, larger Kanzius device ready for use |
| Posted on Wednesday, December 21, 2011 at 6:35 PM |
|
The next step in turning John Kanzius' cancer-killing dream into reality sits in a Millcreek Township laboratory. |
|
|
| Kanzius Cancer Research Foundation Awards New Grant to Support Exciting and Promising Treatment; National Cancer Institute Praises Kanzius Research |
| Posted on Thursday, November 10, 2011 at 3:41 PM |
|
In a move that will advance the Kanzius Noninvasive Radiowave Cancer Treatment closer to the FDA approval and the human clinical trials phase, the Kanzius Cancer Research Foundation has... Read More » |
|
|
| Biomedical Engineers from UC Davis use Kanzius' Method to Kill Cancer Cells |
| Posted on Monday, July 18, 2011 at 3:10 PM |
|
Published July 2011 in IEEE Transactions on Biomedical Engineering Building on John Kanzius’ vision, a team of biomedical engineers from University of California of Davis have developed a delivery system capable of performing the Kanzius Noninvasive Radiowave Cancer Treatment. This manuscript, A Radio-frequency Coupling Network for Heating of Citrate-coated Gold Nanoparticles for Cancer Therapy: Design and Analysis, published in the IEEE Transactions on Biomedical Engineering (one of the leading research journals in the field of biomedical engineering) demonstrates that cancer cells are killed when incubated with gold nanoparticles (GNPs) and exposed to certain levels of Radiofrequency electromagnetic (RF-EM) fields. DOWNLOAD HERE » Read More » |
|
|
| Pancreatic Cancer Research Builds Momentum |
| Posted on Thursday, May 19, 2011 at 3:24 PM |
|
In September, we reported that Dr. Steven Curley, the lead investigator for the Kanzius Project, had three published manuscripts validating the effectiveness of killing human pancreatic cancer cells in vitro using John Kanzius’ methodology. Today, yet another manuscript, “Noninvasive Radiofrequency Field Destruction of Pancreatic Adenocarcinoma Xenografts Treated with Targeted Gold Nanoparticles,” is published in the American Association of Cancer Research’s (AACR) Clinical Cancer Research Journal. Read More » |
|
|
| Live Update |
| Posted on Tuesday, April 19, 2011 at 4:51 PM |
|
On the one year anniversary of the Kanzius Cancer Research Foundation (KCRF) winning the Pepsi Refresh Everything $250,000 grant, the world is invited to participate in the Kanzius Celebration Rally taking place on Thursday, April 28 in historic downtown Erie’s Perry Square. Read More » |
|
|
| 'RF, gold nanoparticles could be key in treating cancer' - Medical Device Daily, January 26, 2011 |
| Posted on Thursday, January 27, 2011 at 3:46 PM |
|
Read this important article about the Kanzius noninvasive radiowave cancer treatment in yesterday’s edition of Medical Device Daily, which bills itself as “the world's leading med-tech news and information source.” Read More » |
|
|
| Displaying 1 - 10 (of 22) · View All | < Prev of 3 Next > |
